Please Wait.....
Report
Antipsychotic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Schizophrenia, Bipolar Disorder, Unipolar Disorder, Dementia, Others), By Drug Classification (First Generation (Typical), Second Generation (Atypical)), By Region and Competition, 2020-2030F
Market Report I 2025-05-16 I 185 Pages I TechSci Research
Market Overview
The Global Antipsychotic Drugs Market was valued at USD 15.29 billion in 2024 and is projected to reach USD 25.48 billion by 2030, expanding at a CAGR of 8.88% during the forecast period. This market serves as a vital component of the pharmaceutical sector, addressing serious mental health disorders such as schizophrenia, bipolar disorder, and treatment-resistant depression. Antipsychotic medications, also known as neuroleptics, are designed to manage and reduce symptoms like hallucinations, delusions, and mood instability by targeting neurotransmitter imbalances, primarily dopamine, in the brain. With mental health conditions on the rise globally, fueled by societal stressors and lifestyle changes, demand for these drugs is escalating. According to the World Health Organization, nearly one in eight people worldwide were living with a mental disorder in 2019. The COVID-19 pandemic further intensified this trend, with significant increases in cases of anxiety and depression. As awareness grows and stigmas diminish, more individuals are seeking treatment, contributing to market expansion. Antipsychotics continue to evolve, offering improved efficacy and tolerability, and playing a key role in long-term psychiatric care and quality-of-life improvement for affected patients.
Key Market Drivers
Rising Prevalence of Mental Health Disorders
The increasing global incidence of psychiatric conditions such as schizophrenia, bipolar disorder, and major depressive disorder is a primary growth driver for the antipsychotic drugs market. This rise is attributed to various factors including changing lifestyles, heightened stress levels, and improved diagnostic capabilities. Greater public awareness and reduced stigma around mental health are prompting more individuals to seek professional care. Consequently, this has led to higher diagnosis rates and an expanding patient population requiring pharmaceutical intervention. Antipsychotic drugs are essential in managing severe mental health symptoms, stabilizing patients, and preventing relapses. Their role in enhancing daily functioning and overall well-being has become increasingly prominent, aligning with the growing focus on holistic mental healthcare.
Key Market Challenges
Adverse Side Effects
A major challenge for the antipsychotic drugs market is the prevalence of adverse effects associated with these medications. Despite the advancements seen with second-generation (atypical) antipsychotics, many patients still experience side effects including significant weight gain, metabolic syndrome, sedation, and sexual dysfunction. These complications can hinder treatment adherence and diminish quality of life. Managing such side effects often requires additional medical oversight and therapeutic adjustments, which can increase healthcare costs and complicate patient care. This challenge underscores the importance of developing newer antipsychotic formulations with improved safety profiles to enhance patient compliance and long-term treatment outcomes.
Key Market Trends
Personalized Medicine Approach
The shift towards personalized medicine is a notable trend shaping the future of the antipsychotic drugs market. Leveraging pharmacogenomics, clinicians are now tailoring treatments to individual genetic profiles, enabling the selection of the most appropriate drug and dosage for each patient. This customized approach minimizes the risk of adverse effects and improves therapeutic efficacy. The integration of genetic testing and data-driven decision-making is helping to move beyond the traditional trial-and-error model, enhancing both clinical outcomes and patient satisfaction. As healthcare systems globally prioritize individualized care, personalized antipsychotic treatment strategies are expected to become a cornerstone in psychiatric therapy.
Key Market Players
- Eli Lily and Company
- AstraZeneca plc
- GlaxoSmithKline plc
- Johnson & Johnson
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer Inc.
- AbbVie Inc.
- Dr. Reddy's Laboratories Limited
- Otsuka Holdings Co., Ltd.
- Teva Pharmaceutical Industries Ltd
Report Scope:
In this report, the Global Antipsychotic Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Antipsychotic Drugs Market, By Application:
o Schizophrenia
o Bipolar Disorder
o Unipolar Disorder
o Dementia
o Others
- Antipsychotic Drugs Market, By Drug Classification:
o First Generation (Typical)
o Second Generation (Atypical)
- Antipsychotic Drugs Market, By Region:
o North America
United States
Mexico
Canada
o Europe
France
Germany
United Kingdom
Italy
Spain
o Asia-Pacific
China
India
South Korea
Japan
Australia
o South America
Brazil
Argentina
Colombia
o Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Antipsychotic Drugs Market.
Available Customizations:
Global Antipsychotic Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Antipsychotic Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Application (Schizophrenia, Bipolar Disorder, Unipolar Disorder, Dementia, Others)
5.2.2. By Drug Classification (First Generation (Typical), Second Generation (Atypical))
5.2.3. By Company (2024)
5.2.4. By Region
5.3. Market Map
6. North America Antipsychotic Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application
6.2.2. By Drug Classification
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Antipsychotic Drugs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Application
6.3.1.2.2. By Drug Classification
6.3.2. Mexico Antipsychotic Drugs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Application
6.3.2.2.2. By Drug Classification
6.3.3. Canada Antipsychotic Drugs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Application
6.3.3.2.2. By Drug Classification
7. Europe Antipsychotic Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Drug Classification
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Antipsychotic Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Drug Classification
7.3.2. Germany Antipsychotic Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Drug Classification
7.3.3. United Kingdom Antipsychotic Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Drug Classification
7.3.4. Italy Antipsychotic Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Application
7.3.4.2.2. By Drug Classification
7.3.5. Spain Antipsychotic Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Application
7.3.5.2.2. By Drug Classification
8. Asia-Pacific Antipsychotic Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By Drug Classification
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Antipsychotic Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Drug Classification
8.3.2. India Antipsychotic Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Drug Classification
8.3.3. South Korea Antipsychotic Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Drug Classification
8.3.4. Japan Antipsychotic Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Drug Classification
8.3.5. Australia Antipsychotic Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Drug Classification
9. South America Antipsychotic Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By Drug Classification
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Antipsychotic Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Drug Classification
9.3.2. Argentina Antipsychotic Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Drug Classification
9.3.3. Colombia Antipsychotic Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Drug Classification
10. Middle East and Africa Antipsychotic Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Drug Classification
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Antipsychotic Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Drug Classification
10.3.2. Saudi Arabia Antipsychotic Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Drug Classification
10.3.3. UAE Antipsychotic Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Drug Classification
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. Competitive Landscape
15.1. Eli Lily and Company
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. AstraZeneca plc
15.3. GlaxoSmithKline plc
15.4. Johnson & Johnson
15.5. Otsuka Pharmaceutical Co, Ltd.
15.6. Pfizer Inc.
15.7. AbbVie Inc.
15.8. Dr. Reddy's Laboratories Limited
15.9. Otsuka Holdings Co., Ltd.
15.10. Teva Pharmaceutical Industries Ltd.
16. Strategic Recommendation
17. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security